Kodiak Sciences (KOD) Other Non-Current Liabilities (2017 - 2026)
Kodiak Sciences' (KOD) quarterly Other Non-Current Liabilities came in at $100.0 million in Q1 2026, little changed YoY from $100.0 million in Q1 2025, and little changed on a QoQ basis from $100.0 million in Q4 2025.
Analysis
Kodiak Sciences (KOD) Other Non-Current Liabilities (2017 - 2026) Analysis & Trends
Kodiak Sciences (KOD) has 10 years of Other Non-Current Liabilities data on file, last reported at $100.0 million in Q1 2026.
- Quarterly Other Non-Current Liabilities changed 0.0% year-over-year to $100.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $100.0 million (changed 0.0% YoY) and the FY2025 annual result came in at $100.0 million, changed 0.0% from the prior year.
- Other Non-Current Liabilities was little changed at $100.0 million in Q1 2026, from $100.0 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $100.0 million in Q4 2023 to a low of $175000.0 in Q3 2022.
- A 5-year average of $78.6 million and a median of $100.0 million in 2023 frame the typical range for Other Non-Current Liabilities.
- The widest YoY moves for Other Non-Current Liabilities: up 47291.47% in 2022, down 99.82% in 2022.
- Tracing KOD's Other Non-Current Liabilities over 5 years: stood at $100.0 million in 2022, then rose by 0.0% to $100.0 million in 2023, then changed by 0.0% to $100.0 million in 2024, then changed by 0.0% to $100.0 million in 2025, then changed by 0.0% to $100.0 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $100.0 million (Q1 2026), $100.0 million (Q4 2025), and $100.0 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Kodiak Sciences | 2.21 Bn | 2.21 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 100.00 Mn |
| Mar 31, 2026 | 100.00 Mn |
| Dec 31, 2025 | 100.00 Mn |
| Sep 30, 2025 | 100.00 Mn |
| Jun 30, 2025 | 100.00 Mn |
| Mar 31, 2025 | 100.00 Mn |
| Dec 31, 2024 | 100.00 Mn |
| Sep 30, 2024 | 100.00 Mn |
| Jun 30, 2024 | 100.00 Mn |
| Mar 31, 2024 | 100.00 Mn |
| Dec 31, 2023 | 100.00 Mn |
| Sep 30, 2023 | 100.00 Mn |
| Jun 30, 2023 | 100.00 Mn |
| Mar 31, 2023 | 100.00 Mn |
| Dec 31, 2022 | 100.00 Mn |
| Sep 30, 2022 | 99.98 Mn |
| Jun 30, 2022 | 99.97 Mn |
| Mar 31, 2022 | 99.96 Mn |
| Dec 31, 2021 | 99.94 Mn |
| Sep 30, 2021 | 99.93 Mn |